News and Events
Learn more about current happenings at Ergomed.
PRESS RELEASE: Guildford, UK – 18 August 2020: Ergomed plc, (LSE: ERGO) (“Ergomed” or the “Company”), a company focused on providing specialized services to the pharmaceutical industry, is pleased to announce that it is the first organization to have achieved the status of compliance with international data protection and privacy standards under the MyData-TRUST label ‘Good Data Protection Practice’ (GDP2®).
As part of Ergomed’s corporate social responsibility, the Company is committed to international compliance with data protection laws. The Company’s activities are focused on ensuring that data protection is the foundation of trustworthy business relationships and an important factor in the reputation of Ergomed as a group.
The intensive MyData-TRUST label process, undertaken over the last two months, required Ergomed to undergo an online assessment with a series of additional one-on-one interviews with a full assessment from the MyData-TRUST team of Ergomed’s current data protection and privacy compliance measures.
Ergomed’s Data Protection Officer, Bosko Vojkic, part of the cross-functional Ergomed team working on this project said: “This label reflects Ergomed’s unwavering commitment to ensuring compliance with data protection requirements throughout the organization. It is important to us that our clients have full confidence in Ergomed and our data protection practices. This label is further encouragement to continue these practices and to build on the solid foundations that Ergomed has already created.”
MyData Trust’s CEO, Xavier Gobert commented: “MyData-TRUST has developed GDP² to drive the processes implemented by organizations to lead, manage and monitor data protection initiatives conducted to comply with GDPR. Organizations such as Ergomed, that can document their compliance with GDP² standards, promote the appropriate ethics and values within the organization. This ensures effective performance management and accountability, communicating risk and control of information to the appropriate areas of the organization, and demonstrating quality of data protection implementation to external parties, such as customers, partners and subjects. I am very pleased that Ergomed is the first company to successfully achieve our label’s audit as they have developed strong state-of-the-art compliance with GDPR.”
|Bosko Vojkic||Tel: +381 (0)60 8115003|
|Ergomed Group Data Protection Officer|
About Ergomed plc
Ergomed provides specialist services to the pharmaceutical industry spanning all phases of clinical development, post-approval pharmacovigilance and medical information. Ergomed’s fast-growing, profitable services business includes an industry leading suite of specialist pharmacovigilance (PV) solutions, integrated under the PrimeVigilance brand, a full range of high-quality contract research and trial management services under the Ergomed brand (CRO), and an internationally recognized specialist expertise in orphan drug development, under PSR. For further information, visit: https://ergomedplc.com.
About MyData Trust
MyData-TRUST specializes in data protection and is exclusively dedicated to the Life Sciences Industry. The Belgian company provides strategic, operational and organizational support, making an important contribution both legally and technically to the success of data protection implementation and a company as a whole. This fast-growing company recently developed Good Data Protection Practices (GDP²). Based on data protection authorities’ methodologies of labeling, GDP² drives the processes implemented by organizations to direct, manage and monitor data protection initiatives which are run to comply with data protection rules. For further information, visit: https://www.mydata-trust.com/